{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:43:18Z","timestamp":1792118598295,"version":"4.4.0"},"reference-count":33,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Hematopoietic stem cell transplantation (HSCT) is a potentially curative procedure that is used in various hematological malignancies. However, among an increasing number of HSCT, the amount of cancer therapy-related cardiac dysfunction (CTRCD) is increasing as well. This study aimed to determine the prevalence of subclinical CTRCD in HSCT patients 12 months after HSCT and to assess the impact of clinical factors on the development of CTRCD. Material and Methods: We included 55 patients who underwent autologous or allogeneic HSCT. The patients were assessed using an echocardiography method before and 12 months after a HSCT procedure. Results: Our study revealed that during the 12-month follow-up period, asymptomatic CTRCD was observed in 15 patients (27.3%), 6 experienced moderate CTRCD, and 9 experienced mild CTRCD. Patients with previous use of anthracyclines tended to have CTRCD more often: nine patients (60%) in the CTRCD group and nine patients (22.5%) in non-CTRCD group. Patients who received the BEAM regimen for conditioning also experienced CTRCD more often: five patients (33.3%) in CTRCD group vs. two patients (5%) in the non-CTRCD group. Conclusions: Our study showed that asymptomatic CTRCD was found in 27.3% of the patients 12 months after HSCT. The BEAM chemotherapy conditioning protocol following prior anthracycline use were identified as factors contributing to the development of CTRCD.<\/jats:p>","DOI":"10.3390\/cancers16223808","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T12:49:56Z","timestamp":1731415796000},"page":"3808","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of Subclinical Cancer Therapy-Related Cardiac Dysfunction in Patients Undergoing Hematopoietic Stem Cell Transplantation: An Echocardiography Study"],"prefix":"10.3390","volume":"16","author":[{"given":"Audrone","family":"Vaitiekiene","sequence":"first","affiliation":[{"name":"Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Migle","family":"Kulboke","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"},{"name":"Oncology Institute, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Bieseviciene","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austeja","family":"Kaunaite","sequence":"additional","affiliation":[{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auste","family":"Markeviciute","sequence":"additional","affiliation":[{"name":"Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-2032","authenticated-orcid":false,"given":"Agne","family":"Bartnykaite","sequence":"additional","affiliation":[{"name":"Oncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benas","family":"Kireilis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Rinkuniene","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antanas","family":"Jankauskas","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"},{"name":"Institute of Cardiology, Lithuanian University of Health Sciences, 47181 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignas","family":"Gaidamavicius","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"},{"name":"Oncology Institute, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolandas","family":"Gerbutavicius","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"},{"name":"Oncology Institute, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9583-4475","authenticated-orcid":false,"given":"Domas","family":"Vaitiekus","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"},{"name":"Oncology Institute, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gintare","family":"Sakalyte","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"},{"name":"Institute of Cardiology, Lithuanian University of Health Sciences, 47181 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta Justina","family":"Vaskelyte","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania"},{"name":"Institute of Cardiology, Lithuanian University of Health Sciences, 47181 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Zhao, Y., He, R., Oerther, S., Zhou, W., Vosough, M., and Hassan, M. (2022). Cardiovascular Complications in Hematopoietic Stem Cell Transplanted Patients. J. Pers. Med., 12.","DOI":"10.3390\/jpm12111797"},{"key":"ref_2","unstructured":"Ryan, T.D., Hayek, S., and Rotz, S. (2024, November 05). Review of Late CV Effects After Hematopoietic Stem Cell Transplantation. Am. Coll. Cardiol., Available online: https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2021\/01\/25\/14\/28\/review-of-late-cv-effects-after-hematopoietic-stem-cell-transplantation."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3324\/haematol.2021.280568","article-title":"Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling","volume":"108","author":"Lawless","year":"2022","journal-title":"Haematologica"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3324\/haematol.2021.279189","article-title":"One and a half million hematopoietic stem cell transplants: Continuous and differential improvement in worldwide access with the use of non-identical family donors","volume":"107","author":"Niederwieser","year":"2022","journal-title":"Haematologica"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/s41409-021-01427-2","article-title":"Cardiac complications associated with hematopoietic stem-cell transplantation","volume":"56","author":"Ohmoto","year":"2021","journal-title":"Bone Marrow Transpl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11936-016-0447-9","article-title":"Cardiovascular Complications of Hematopoietic Stem Cell Transplantation","volume":"18","author":"Blaes","year":"2016","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s11239-020-02344-9","article-title":"Cardiovascular Disease and its Management in Children and Adults Undergoing Hematopoietic Stem Cell Transplantation","volume":"51","author":"Rotz","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1734-1140(09)70026-X","article-title":"Pharmacology of dimethyl sulfoxide in cardiac and CNS damage","volume":"61","author":"Jacob","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e002007","DOI":"10.1136\/openhrt-2022-002007","article-title":"Early-onset cardiac dysfunction following allogeneic haematopoietic stem cell transplantation","volume":"9","author":"Moriyama","year":"2022","journal-title":"Open Heart"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.2015.60.8125","article-title":"Heart failure and asymptomatic left ventricular systolic dysfunction in lymphoma survivors treated with autologous stem-cell transplantation: A national cross-sectional study","volume":"33","author":"Murbraech","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s13287-020-01984-1","article-title":"Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells","volume":"11","author":"Liu","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_15","first-page":"24","article-title":"Chemotherapy Agents That Cause Cardiotoxicity","volume":"42","author":"Thomas","year":"2017","journal-title":"US Pharm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/annonc\/mdu339.20","article-title":"Cardiotoxicity of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cells Transplantation in Patients with Malignant Lymphomas. what is Worse-Beam or Cbv?","volume":"25","author":"Sarzhevskiy","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-030-43032-0_15","article-title":"Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention","volume":"1257","author":"Bhagat","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1182\/blood-2011-06-358226","article-title":"Incidence and Predictors of Congestive Heart Failure After Autologous Hematopoietic Cell Transplantation","volume":"118","author":"Armenian","year":"2011","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bmt.1702783","article-title":"Severe Cardiac Toxicity in Hematological Stem Cell Transplantation: Predictive Value of Reduced Left Ventricular Ejection Fraction","volume":"27","author":"Fujimaki","year":"2001","journal-title":"Bone Marrow Transpl."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaccao.2020.06.011","article-title":"Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation","volume":"2","author":"Massey","year":"2020","journal-title":"JACC CardioOncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40959-024-00244-y","article-title":"Anthracycline Therapy Induces an Early Decline of Cardiac Contractility in Low-Risk Patients with Breast Cancer","volume":"10","author":"Nienhaus","year":"2024","journal-title":"Cardio Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Di Lisi, D., Madaudo, C., Di Fazio, L., Gulotta, A., Triolo, O.F., Galassi, A.R., Incorvaia, L., Russo, A., and Novo, G. (2023). Higher Incidence of Cancer Therapy-Related Cardiac Dysfunction in the COVID-19 Era: A Single Cardio-Oncology Center Experience. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10010023"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Mauro, C., Capone, V., Cocchia, R., Cademartiri, F., Riccardi, F., Arcopinto, M., Alshahid, M., Anwar, K., Carafa, M., and Carbone, A. (2023). Cardiovascular Side Effects of Anthracyclines and HER2 Inhibitors among Patients with Breast Cancer: A Multidisciplinary Stepwise Approach for Prevention, Early Detection, and Treatment. J. Clin. Med., 12.","DOI":"10.3390\/jcm12062121"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaccao.2022.01.101","article-title":"The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review","volume":"4","author":"Omland","year":"2022","journal-title":"JACC CardioOncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41514-024-00135-7","article-title":"A Review of the Pathophysiological Mechanisms of Doxorubicin-Induced Cardiotoxicity and Aging","volume":"10","author":"Linders","year":"2024","journal-title":"npj Aging"},{"key":"ref_26","first-page":"395","article-title":"Cardiotoxicity Associated with Cancer Therapy: Pathophysiology and Prevention","volume":"32","year":"2013","journal-title":"Rev. Port. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11936-014-0315-4","article-title":"Anthracycline-Induced Cardiotoxicity: A Review of Pathophysiology, Diagnosis, and Treatment","volume":"16","author":"Raj","year":"2014","journal-title":"Curr. Treat. Options Cardio Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","article-title":"Anthracycline cardiotoxicity: An update on mechanisms, monitoring and prevention","volume":"104","author":"Henriksen","year":"2018","journal-title":"Heart"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e2254677","DOI":"10.1001\/jamanetworkopen.2022.54677","article-title":"Heart Failure in Patients with Cancer Treated With Anthracyclines\u2014Revisiting the Foundation of Cardio-Oncology","volume":"6","author":"Fradley","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2023.02.019","article-title":"Anthracycline-Induced Cardiotoxicity\u2014Are We About to Clear This Hurdle?","volume":"185","author":"Dempke","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Chaulin, A.M. (2023). The Essential Strategies to Mitigate Cardiotoxicity Caused by Doxorubicin. Life, 13.","DOI":"10.3390\/life13112148"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11897-023-00590-5","article-title":"Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies","volume":"20","author":"Tini","year":"2023","journal-title":"Curr. Heart Fail Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12012-019-09556-3","article-title":"Impact of arterial hypertension on Doxorubicin-Based Chemotherapy-Induced subclinical cardiac damage in breast cancer patients","volume":"20","author":"Vaitiekus","year":"2020","journal-title":"Cardiovasc. Toxicol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/22\/3808\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:30:59Z","timestamp":1760113859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/22\/3808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":33,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["cancers16223808"],"URL":"https:\/\/doi.org\/10.3390\/cancers16223808","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]}}}